发明名称 SPIRO BRIDGED AND UNBRIDGED HETEROCYCLIC COMPOUNDS
摘要 Compounds (I) and (II), including enantiomers, racemates and acid addition and quaternary salts, are for treating diseases of the central and peripheral nervous system, (see formula I and II) wherein in formula (I) Q is (CH2)m or C(CH3)2 attached to the 1',4' or 1',5' positions of the six-membered ring (m = 1, 2 or 3.) and in formula (II) Q is two hydrogen atoms, (CH2)m or C(CH3)2 (m = 1, 2 or 3) and n and p are each independently 0, 1, 2 or 3, provided that n + p = 2-3; R.degree. is hydrogen, methyl or OH; (see formula III) is (see formula IV), (see formula V), (see formula VI or VII) R and R' are independently H, NH2, NH-C1-6-alkyl, N(C1-6-alkyl)2, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C3-7- cycloalkyl, C1-6- alkyl substituted by 1-6 halogen atoms, HO- C1-6-alkyl, C1-6- alkoxy, C1-6-alkylthio, C1-6-alkoxy-C1-6-alkyl, carboxy-C1-6- alkyl, (C1-6-alkoxy)carbonyl-C1-6-alkyl, amino-C1-6-alkyl, mono- (C1-6-alkyl)amino-C1-6-alkyl, di-(C1-6-alkyl)amino-C1-6-alkyl, 2- oxo-pyrrolidin-1-yl-methyl, Ar, di(Ar)methylol, or (Ar)1-2C1-6 alkyl, or R' may be C1-6-alkanoyl or Arcarbonyl; and Ar denotes Ph optionally substituted by 1-3 of halogen, C1-6-alkyl, C1-6- alkoxy and GF3, subject to certain provisos.
申请公布号 CA2039826(C) 申请公布日期 2002.01.15
申请号 CA19912039826 申请日期 1991.04.04
申请人 FISHER, ABRAHAM;SEGALL, YOFFI;SHIRIN, EZRA;KARTON, YISHAI;MESHULAM, HAIM 发明人 FISHER, ABRAHAM;SEGALL, YOFFI;SHIRIN, EZRA;KARTON, YISHAI;MESHULAM, HAIM
分类号 A61K31/435;A61K31/439;A61K31/445;A61P25/00;A61P25/02;A61P25/28;C07D453/00;C07D498/10;C07D498/20;C07D513/10;(IPC1-7):C07D453/00;A61K31/42;A61K31/425 主分类号 A61K31/435
代理机构 代理人
主权项
地址